Haemonetics
293 hedge funds and large institutions have $4.52B invested in Haemonetics in 2018 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 90 increasing their positions, 105 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
293
Holders Change
+32
Holders Change %
+12.26%
% of All Funds
6.72%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
68
Increased
90
Reduced
105
Closed
34
Calls
$1.23M
Puts
$15.3M
Net Calls
-$14.1M
Net Calls Change
-$15.1M
Top Buyers
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$112M |
| 2 |
Renaissance Technologies
New York
|
+$58.3M |
| 3 |
Man Group
London,
United Kingdom
|
+$43.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$36.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$35.9M |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$107M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$89.4M |
| 3 |
Millennium Management
New York
|
-$85.5M |
| 4 |
BlackRock
New York
|
-$82.2M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$74.6M |
